and P

and P.A.; formal analysis, D.R.; investigation, R.B. cannot be concluded from the course of treatment, that (2) an increase in the dose and variability of outcome with treatment duration indicates the ongoing induction of NABs over time, that (3) the

D

D. tissue damage. Subcutaneous abscess formation was not Teglicar prevented by immunization with AT62. However, in a pores and skin necrosis illness model, immunization with the AT62 vaccine resulted in smaller lesions and reduced mouse weight loss compared Rabbit Polyclonal

M

M. of 1 1,877, 7,571, 24,923, and 83,197 ng/ml following doses of 0.1, 0.4, 1.2, and 4.0 mg/kg body weight, respectively. The mean elimination half-life was between 70 and 95 h. The mean volume of distribution was between 4.76 and

These were conducted relative to the Queensland Government Animal Research Act 2001, associated Animal Care and Protection Regulations (2002 and 2008) as well as the Australian Code of Practice for the Care and Usage of Animals for Scientific Purposes, 8th Edition (National Health insurance and Medical Research Council, 2013)

These were conducted relative to the Queensland Government Animal Research Act 2001, associated Animal Care and Protection Regulations (2002 and 2008) as well as the Australian Code of Practice for the Care and Usage of Animals for Scientific Purposes, 8th